EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and antibacterial activity of pleuromutilin derivatives

Hui-Xian Liu, Wen-Yu Yao, Ge Cui, Jing Zhou, Hao Yan, Hui Guo, Yu-Wei Wang iD, Yue Zhang

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Hui-Xian Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, PR China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Diterpenes, Drug Design, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: S&T Program of Hebei (No. H2020423279), Xianyang Innovation Team of Innovation Capability Support Program (No. L2023-CXNL-CXTD-004), National Natural Science F….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper reports the design, synthesis, and antibacterial activity study of pleuromutilin derivatives with 2‐methyl‐4‐nitroaniline and 2‐methoxy‐4‐nitroaniline side chains at the C22 position. The structures of the new compounds were characterized by 1 H‐NMR, 13 C‐NMR and HRMS. The inhibitory activity of the compounds against MSSA, pyogeniccoccus , streptococcus , and MRSA strains was determined using the micro broth dilution method. The results showed that the compounds exhibited certain activity against Gram‐positive bacteria, among which compounds A8a, A8b, A8c, A8d, and A7 demonstrated superior antibacterial activity against MSSA, MRSA, and pyogeniccoccus compared to tiamulin, although the derivatives showed lower antibacterial activity against streptococcus compared to the control drug. Based on the favorable in vitro activity of A8c, the time‐kill kinetics against MRSA were evaluated, revealing that compound A8c could inhibit bacterial proliferation in a concentration‐dependent manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsDiterpenesDrug DesignMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsPleuromutilinsPolycyclic CompoundsGram-Positive BacteriaStreptococcusStructure-Activity RelationshipAniline CompoundsNitro Compounds

Stichwörter der Autor:innen

antibioticsderivativesdesignpleuromutilinsynthesis

Substanzen

Anti-Bacterial AgentsDiterpenesPleuromutilinsPolycyclic Compounds2-methyl-4-nitroanilineAniline CompoundsNitro Compounds

Autor:innen und Institutionen

  • College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, PR China.
  • Jinan University College of Pharmacy, Guangzhou, PR China.
  • School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang, PR China.
  • Hebei Research Center of Pharmaceutical and Chemical Engineering, Shijiazhuang, PR China.
  • Hebei Province Key Laboratory of Molecular Chemistry for Drug, Shijiazhuang, PR China.

ORCID-Profile: Yu-Wei Wang

Förderung

  • S&T Program of Hebei (No. H2020423279), Xianyang Innovation Team of Innovation Capability Support Program (No. L2023-CXNL-CXTD-004), National Natural Science F…

Zitieren

APA

Liu, H. X., Yao, W. Y., Cui, G., Zhou, J., Yan, H., Guo, H., Wang, Y. W., & Zhang, Y. (2024). Design, synthesis, and antibacterial activity of pleuromutilin derivatives. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14554

Vancouver

Liu HX, Yao WY, Cui G, Zhou J, Yan H, Guo H, et al. Design, synthesis, and antibacterial activity of pleuromutilin derivatives. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14554

BibTeX
@article{Liu2024,
  author = {Liu, Hui-Xian and Yao, Wen-Yu and Cui, Ge and Zhou, Jing and Yan, Hao and Guo, Hui and Wang, Yu-Wei and Zhang, Yue},
  title = {Design, synthesis, and antibacterial activity of pleuromutilin derivatives},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14554}
}
Kostenlos starten →